|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.36 USD | -0.26% |
|
-0.97% | +72.09% |
| 11-13 | Alignment Healthcare Insider Sold Shares Worth $2,936,772, According to a Recent SEC Filing | MT |
| 10-31 | UBS Adjusts Alignment Healthcare Price Target to $18 From $17, Maintains Neutral Rating | MT |
| Capitalization | 3.87B 3.3B 3.08B 2.9B 5.34B 351B 5.83B 35.98B 13.96B 165B 14.54B 14.23B 603B | P/E ratio 2025 * |
-179x | P/E ratio 2026 * | 213x |
|---|---|---|---|---|---|
| Enterprise value | 3.61B 3.08B 2.87B 2.7B 4.98B 327B 5.44B 33.54B 13.01B 154B 13.55B 13.26B 562B | EV / Sales 2025 * |
0.92x | EV / Sales 2026 * | 0.7x |
| Free-Float |
55.92% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Alignment Healthcare, Inc.
| 1 day | -0.26% | ||
| 1 week | -0.97% | ||
| Current month | +0.78% | ||
| 1 month | +15.44% | ||
| 3 months | +20.70% | ||
| 6 months | +29.59% | ||
| Current year | +72.09% |
| 1 week | 18.76 |  | 20.05 |
| 1 month | 15.84 | | 20.05 |
| Current year | 11.3 | | 21.06 |
| 1 year | 10.18 | | 21.06 |
| 3 years | 4.46 | | 21.06 |
| 5 years | 4.46 | | 28.59 |
| 10 years | 4.46 | | 28.59 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Kao
CEO | Chief Executive Officer | 63 | 31/12/2013 |
James Head
DFI | Director of Finance/CFO | 60 | 01/05/2025 |
Dawn Maroney
PSD | President | 57 | 12/01/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
John Kao
BRD | Director/Board Member | 63 | 31/12/2013 |
David Hodgson
BRD | Director/Board Member | 68 | 31/12/2013 |
Mark McClellan
BRD | Director/Board Member | 61 | 31/12/2013 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 0.03% | 324 M€ | +9.21% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.26% | -0.97% | +69.08% | +59.87% | 3.87B | |
| +1.52% | +3.30% | -34.32% | -36.49% | 310B | |
| -0.32% | +8.56% | -5.86% | -30.86% | 79.8B | |
| +0.90% | +3.49% | -2.54% | -16.82% | 73.38B | |
| +0.74% | +4.11% | -2.07% | -48.68% | 32.29B | |
| +0.96% | +6.55% | -31.25% | -50.91% | 20.08B | |
| +0.96% | +10.96% | -44.39% | -51.68% | 8.66B | |
| +2.69% | +11.20% | +82.82% | -15.93% | 2.3B | |
| -1.82% | +4.65% | -13.18% | +143.24% | 1.4B | |
| -2.25% | -0.17% | -24.41% | - | 385M | |
| Average | +0.31% | +5.17% | -0.61% | -5.36% | 53.18B | |
| Weighted average by Cap. | +1.06% | +4.42% | -22.43% | -33.20% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 3.94B 3.36B 3.14B 2.95B 5.43B 357B 5.93B 36.59B 14.19B 168B 14.78B 14.47B 614B | 5.13B 4.37B 4.08B 3.84B 7.06B 464B 7.72B 47.61B 18.47B 219B 19.23B 18.83B 798B |
| Net income | -24.6M -20.96M -19.58M -18.42M -33.91M -2.23B -37.05M -229M -88.64M -1.05B -92.31M -90.37M -3.83B | 20.14M 17.16M 16.03M 15.08M 27.77M 1.82B 30.33M 187M 72.57M 860M 75.58M 73.99M 3.14B |
| Net Debt | -263M -224M -209M -197M -362M -23.8B -396M -2.44B -947M -11.22B -986M -965M -40.92B | -302M -258M -241M -226M -417M -27.39B -455M -2.81B -1.09B -12.91B -1.13B -1.11B -47.1B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/12/25 | 19.36 $ | -0.26% | 2,915,735 |
| 11/12/25 | 19.41 $ | +2.64% | 4,867,873 |
| 10/12/25 | 18.91 $ | -1.56% | 2,094,708 |
| 09/12/25 | 19.21 $ | -0.77% | 1,530,371 |
| 08/12/25 | 19.36 $ | -0.97% | 2,547,872 |
Delayed Quote Nasdaq, December 12, 2025 at 09:00 pm
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ALHC Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition